05/21/2025
3:16 PM | Acurx Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
05/20/2025
2:32 PM | Acurx Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
05/13/2025
6:12 AM | Acurx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
3:30 PM | Acurx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/14/2025
11:15 PM | Acurx Pharmaceuticals (Filer)
| Form EFFECT | |
03/20/2025
8:13 PM | Acurx Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
03/19/2025
11:15 PM | Acurx Pharmaceuticals (Filer)
| Form EFFECT | |
03/18/2025
6:12 AM | Acurx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/17/2025
3:36 PM | Acurx Pharmaceuticals (Filer)
| Form POS AM | |
03/17/2025
3:37 PM | Acurx Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/10/2025
6:35 AM | Acurx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for ACXP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Acurx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
03/10/2025
6:30 AM | Acurx Pharmaceuticals (Filer)
| Form 424B5 | |
02/26/2025
3:10 PM | Acurx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2025
11:15 PM | Acurx Pharmaceuticals (Filer)
| Form EFFECT | |
02/06/2025
4:47 PM | Acurx Pharmaceuticals (Issuer)
Shawah Robert G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
4:45 PM | Acurx Pharmaceuticals (Issuer)
DELUCCIA ROBERT J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
4:46 PM | Acurx Pharmaceuticals (Issuer)
LUCI DAVID P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
4:11 PM | Acurx Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
01/08/2025
3:31 PM | Acurx Pharmaceuticals (Issuer)
LUCI DAVID P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
3:31 PM | Acurx Pharmaceuticals (Issuer)
Sailer Carl (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
3:32 PM | Acurx Pharmaceuticals (Issuer)
Scodari Joseph C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
3:30 PM | Acurx Pharmaceuticals (Issuer)
DEAN JACK H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
3:30 PM | Acurx Pharmaceuticals (Issuer)
DELUCCIA ROBERT J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
3:31 PM | Acurx Pharmaceuticals (Issuer)
Donohue James J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
9:00 AM | Acurx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
9:03 AM | Acurx Pharmaceuticals (Filer)
| Form 424B5 | |
01/06/2025
2:51 PM | Acurx Pharmaceuticals (Filer)
| Form 424B3 | |
11/13/2024
6:06 AM | Acurx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
6:13 AM | Acurx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
